Skip to content

Evaluation of waterbased and land-based training in overweight and obese subjects, a randomized, controlled pilot study

Evaluation of waterbased and land-based training in overweight and obese subjects, a randomized, controlled pilot study - AQFIT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014004
Enrollment
90
Registered
2018-07-31
Start date
2018-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E66.9

Interventions

Group 1: The water based exercise group (Aquacycling) receives a training program for 45 minutes in thermoneutral water (temperature> 28 ° C) twice a week in groups for 10 weeks ("Vita classica" in Ba

Sponsors

IBF Balneologie am IUK, Uniklinik Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: •BMI = 25 kg/m² •= 18 years, •signed consent •abilitiy to participate in the trial

Exclusion criteria

Exclusion criteria: • Participation in other studies • serious illnesses that make physical training impossible ? relevant diseases of the cardiovascular system: e.g. Heart failure (dyspnoea at rest, leg edema), symptomatic PAOD, exercise-related or even unstable angina pectoris, • acute infection, fever • Reasons that exclude training on land ? e.g. relevant musculoskeletal disorders (e.g., severe osteoarthritis), paralysis • reasons excluding public baths ? e.g. open skin injuries, waterborne diseases • Aquafitness or scheduled on-shore training (> 1 time per week) in the last 3 months • pregnancy, lactation, • Diseases that make participation in the study impossible, e.g. Dementia or mental illness • Conditions that do not make study participation possible, e.g. insufficient knowledge of German, no way to get there or time for training or measurements

Design outcomes

Primary

MeasureTime frame
6-minutes-walk/run-test before and after therapy, between groups

Secondary

MeasureTime frame
bodyweight Waist-hip-circumference SF12 IPAQ (international Physical Activity Questionneaire) Preference of therapy Adverse effects Blood values (Chol, HDL, LDL, TG, Hba1c) before and after and 12 weeks after therapy, between groups

Countries

Germany

Contacts

Public ContactJohannes Naumann

IBF Balneologie am IUK, Uniklinik Freiburg

johannes.naumann@uniklinik-freiburg.de07633-4008-501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026